3tmk › Citations

Crystal structure of yeast thymidylate kinase complexed with the bisubstrate inhibitor P1-(5'-adenosyl) P5-(5'-thymidyl) pentaphosphate (TP5A) at 2.0 A resolution: implications for catalysis and AZT activation.

Lavie A, Konrad M, Brundiers R, Goody RS, Schlichting I, Reinstein J
Biochemistry 37 3677-86 (1998)
Cited: 42 times
EuropePMC logo PMID: 9521686

Abstract

The crystal structure of yeast thymidylate kinase (TmpK) complexed with the bisubstrate inhibitor P1-(5'-adenosyl) P5-(5'-thymidyl) pentaphosphate (TP5A) was determined at 2.0 A resolution. In this complex, TmpK adopts a closed conformation with a region (LID) of the protein closing upon the substrate and forming a helix. The interactions of TmpK and TP5A strongly suggest that arginine 15, which is located in the phosphate binding loop (P-loop) sequence, plays a catalytic role by interacting with an oxygen atom of the transferred phosphoryl group. Unlike other nucleoside monophosphate kinases where basic residues from the LID region participate in stabilizing the transition state, TmpK lacks such residues in the LID region. We attribute this function to Arg 15 of the P-loop. TmpK plays an important role in the phosphorylation of the AIDS prodrug AZT. The structures of TmpK with dTMP and with AZT-MP [Lavie, A., et al. (1997) Nat. Struct. Biol. 4, 601-604] implicate the movement of Arg15 in response to AZT-MP binding as an important factor in the 200-fold reduced catalytic rate with AZT-MP. TmpK from Escherichia coli lacks this arginine in its P-loop while having basic residues in the LID region. This suggested that, if such a P-loop movement were to occur in the E. coli TmpK upon AZT-MP binding, it should not have such a detrimental effect on catalysis. This hypothesis was tested, and as postulated, E. coli TmpK phosphorylates AZT-MP only 2.5 times slower than dTMP.

Articles - 3tmk mentioned but not cited (3)

  1. From the similarity analysis of protein cavities to the functional classification of protein families using cavbase. Kuhn D, Weskamp N, Schmitt S, Hüllermeier E, Klebe G. J Mol Biol 359 1023-1044 (2006)
  2. Fingerprint-based structure retrieval using electron density. Yin S, Dokholyan NV. Proteins 79 1002-1009 (2011)
  3. Biochemical Characterizations of Human TMPK Mutations Identified in Patients with Severe Microcephaly: Single Amino Acid Substitutions Impair Dimerization and Abolish Their Catalytic Activity. Frisk JH, Vanoevelen JM, Bierau J, Pejler G, Eriksson S, Wang L. ACS Omega 6 33943-33952 (2021)


Reviews citing this publication (1)

  1. The enantioselectivity of enzymes involved in current antiviral therapy using nucleoside analogues: a new strategy? Maury G. Antivir Chem Chemother 11 165-189 (2000)

Articles citing this publication (38)

  1. Evolution and classification of P-loop kinases and related proteins. Leipe DD, Koonin EV, Aravind L. J Mol Biol 333 781-815 (2003)
  2. How guanylate-binding proteins achieve assembly-stimulated processive cleavage of GTP to GMP. Ghosh A, Praefcke GJ, Renault L, Wittinghofer A, Herrmann C. Nature 440 101-104 (2006)
  3. Triphosphate structure of guanylate-binding protein 1 and implications for nucleotide binding and GTPase mechanism. Prakash B, Renault L, Praefcke GJ, Herrmann C, Wittinghofer A. EMBO J 19 4555-4564 (2000)
  4. Sequence analysis of bacteriophage T4 DNA packaging/terminase genes 16 and 17 reveals a common ATPase center in the large subunit of viral terminases. Mitchell MS, Matsuzaki S, Imai S, Rao VB. Nucleic Acids Res 30 4009-4021 (2002)
  5. X-ray structure of TMP kinase from Mycobacterium tuberculosis complexed with TMP at 1.95 A resolution. Li de la Sierra I, Munier-Lehmann H, Gilles AM, Bârzu O, Delarue M. J Mol Biol 311 87-100 (2001)
  6. Insights into the phosphoryltransfer mechanism of human thymidylate kinase gained from crystal structures of enzyme complexes along the reaction coordinate. Ostermann N, Schlichting I, Brundiers R, Konrad M, Reinstein J, Veit T, Goody RS, Lavie A. Structure 8 629-642 (2000)
  7. Thymidylate kinase of Mycobacterium tuberculosis: a chimera sharing properties common to eukaryotic and bacterial enzymes. Munier-Lehmann H, Chaffotte A, Pochet S, Labesse G. Protein Sci 10 1195-1205 (2001)
  8. Structural basis for efficient phosphorylation of 3'-azidothymidine monophosphate by Escherichia coli thymidylate kinase. Lavie A, Ostermann N, Brundiers R, Goody RS, Reinstein J, Konrad M, Schlichting I. Proc Natl Acad Sci U S A 95 14045-14050 (1998)
  9. Structures of escherichia coli CMP kinase alone and in complex with CDP: a new fold of the nucleoside monophosphate binding domain and insights into cytosine nucleotide specificity. Briozzo P, Golinelli-Pimpaneau B, Gilles AM, Gaucher JF, Burlacu-Miron S, Sakamoto H, Janin J, Bârzu O. Structure 6 1517-1527 (1998)
  10. Nucleoside analogues are activated by bacterial deoxyribonucleoside kinases in a species-specific manner. Sandrini MP, Clausen AR, On SL, Aarestrup FM, Munch-Petersen B, Piskur J. J Antimicrob Chemother 60 510-520 (2007)
  11. Crystal structure of poxvirus thymidylate kinase: an unexpected dimerization has implications for antiviral therapy. Caillat C, Topalis D, Agrofoglio LA, Pochet S, Balzarini J, Deville-Bonne D, Meyer P. Proc Natl Acad Sci U S A 105 16900-16905 (2008)
  12. Crystal structure of dephospho-coenzyme A kinase from Haemophilus influenzae. Obmolova G, Teplyakov A, Bonander N, Eisenstein E, Howard AJ, Gilliland GL. J Struct Biol 136 119-125 (2001)
  13. Structural basis for the efficient phosphorylation of AZT-MP (3'-azido-3'-deoxythymidine monophosphate) and dGMP by Plasmodium falciparum type I thymidylate kinase. Whittingham JL, Carrero-Lerida J, Brannigan JA, Ruiz-Perez LM, Silva AP, Fogg MJ, Wilkinson AJ, Gilbert IH, Wilson KS, González-Pacanowska D. Biochem J 428 499-509 (2010)
  14. Nucleoside analogues as inhibitors of thymidylate kinases: possible therapeutic applications. Pochet S, Dugue L, Douguet D, Labesse G, Munier-Lehmann H. Chembiochem 3 108-110 (2002)
  15. Classification of common functional loops of kinase super-families. Fernandez-Fuentes N, Hermoso A, Espadaler J, Querol E, Aviles FX, Oliva B. Proteins 56 539-555 (2004)
  16. Coupling of NAD+ biosynthesis and nicotinamide ribosyl transport: characterization of NadR ribonucleotide kinase mutants of Haemophilus influenzae. Merdanovic M, Sauer E, Reidl J. J Bacteriol 187 4410-4420 (2005)
  17. Crystal structure of human nicotinamide riboside kinase. Khan JA, Xiang S, Tong L. Structure 15 1005-1013 (2007)
  18. Mycobacterium tuberculosis thymidylate kinase: structural studies of intermediates along the reaction pathway. Fioravanti E, Haouz A, Ursby T, Munier-Lehmann H, Delarue M, Bourgeois D. J Mol Biol 327 1077-1092 (2003)
  19. Synthesis and evaluation of α-thymidine analogues as novel antimalarials. Cui H, Carrero-Lérida J, Silva AP, Whittingham JL, Brannigan JA, Ruiz-Pérez LM, Read KD, Wilson KS, González-Pacanowska D, Gilbert IH. J Med Chem 55 10948-10957 (2012)
  20. Structures of S. aureus thymidylate kinase reveal an atypical active site configuration and an intermediate conformational state upon substrate binding. Kotaka M, Dhaliwal B, Ren J, Nichols CE, Angell R, Lockyer M, Hawkins AR, Stammers DK. Protein Sci 15 774-784 (2006)
  21. The highly similar TMP kinases of Yersinia pestis and Escherichia coli differ markedly in their AZTMP phosphorylating activity. Chenal-Francisque V, Tourneux L, Carniel E, Christova P, Li de la Sierra I, Bârzu O, Gilles AM. Eur J Biochem 265 112-119 (1999)
  22. Characterization of Streptococcus pneumoniae thymidylate kinase: steady-state kinetics of the forward reaction and isothermal titration calorimetry. Petit CM, Koretke KK. Biochem J 363 825-831 (2002)
  23. Structure guided development of novel thymidine mimetics targeting Pseudomonas aeruginosa thymidylate kinase: from hit to lead generation. Choi JY, Plummer MS, Starr J, Desbonnet CR, Soutter H, Chang J, Miller JR, Dillman K, Miller AA, Roush WR. J Med Chem 55 852-870 (2012)
  24. Crystal structures of GMP kinase in complex with ganciclovir monophosphate and Ap5G. Hible G, Daalova P, Gilles AM, Cherfils J. Biochimie 88 1157-1164 (2006)
  25. Cloning of the guanylate kinase homologues AGK-1 and AGK-2 from Arabidopsis thaliana and characterization of AGK-1. Kumar V, Spangenberg O, Konrad M. Eur J Biochem 267 606-615 (2000)
  26. Mechanisms of substrate selectivity for Bacillus anthracis thymidylate kinase. Carnrot C, Wang L, Topalis D, Eriksson S. Protein Sci 17 1486-1493 (2008)
  27. Insights into open/closed conformations of the catalytically active human guanylate kinase as investigated by small-angle X-ray scattering. Jain R, Khan N, Menzel A, Rajkovic I, Konrad M, Techert S. Eur Biophys J 45 81-89 (2016)
  28. Structural and functional characterization of the Mycobacterium tuberculosis uridine monophosphate kinase: insights into the allosteric regulation. Labesse G, Benkali K, Salard-Arnaud I, Gilles AM, Munier-Lehmann H. Nucleic Acids Res 39 3458-3472 (2011)
  29. ATP interacts with the CPVT mutation-associated central domain of the cardiac ryanodine receptor. Blayney L, Beck K, MacDonald E, D'Cruz L, Nomikos M, Griffiths J, Thanassoulas A, Nounesis G, Lai FA. Biochim Biophys Acta 1830 4426-4432 (2013)
  30. Molecular cloning and characterization of Brugia malayi thymidylate kinase. Doharey PK, Suthar MK, Verma A, Kumar V, Yadav S, Balaramnavar VM, Rathaur S, Saxena AK, Siddiqi MI, Saxena JK. Acta Trop 133 83-92 (2014)
  31. The novel fluorescent CDP-analogue (Pbeta)MABA-CDP is a specific probe for the NMP binding site of UMP/CMP kinase. Rudolph MG, Veit TJ, Reinstein J. Protein Sci 8 2697-2704 (1999)
  32. Synthesis and binding of stable bisubstrate ligands for phosphoglycerate kinase. Williams DM, Jakeman DL, Vyle JS, Williamson MP, Blackburn GM. Bioorg Med Chem Lett 8 2603-2608 (1998)
  33. Folding properties of cytosine monophosphate kinase from E. coli indicate stabilization through an additional insert in the NMP binding domain. Beitlich T, Lorenz T, Reinstein J. PLoS One 8 e78384 (2013)
  34. Insights into the structure-function relationship of Brugia malayi thymidylate kinase (BmTMK). Doharey PK, Singh SK, Verma P, Verma A, Rathaur S, Saxena JK. Int J Biol Macromol 88 565-571 (2016)
  35. Multisubstrate adduct inhibitors: drug design and biological tools. Le Calvez PB, Scott CJ, Migaud ME. J Enzyme Inhib Med Chem 24 1291-1318 (2009)
  36. Substitution of an alanine residue for glycine 146 in TMP kinase from Escherichia coli is responsible for bacterial hypersensitivity to bromodeoxyuridine. Tourneux L, Bucurenci N, Lascu I, Sakamoto H, Briand G, Gilles AM. J Bacteriol 180 4291-4293 (1998)
  37. Modulated nucleoside kinases as tools to improve the activation of therapeutic nucleoside analogues. Monnerjahn C, Konrad M. Chembiochem 4 143-146 (2003)
  38. Stabilization of Active Site Dynamics Leads to Increased Activity with 3'-Azido-3'-deoxythymidine Monophosphate for F105Y Mutant Human Thymidylate Kinase. Fucci IJ, Sinha K, Rule GS. ACS Omega 5 2355-2367 (2020)


Quick links